Commission Implementing Regulation (EU) 2025/1795 of 9 September 2025 concerning the authorisation of riboflavin (vitamin B2) produced with Bacillus subtilis CGMCC 7.449 and a preparation of riboflavin produced with Bacillus subtilis CGMCC 7.449, as feed additives for all animal species
Proposed act with possible EEA relevance
Act under scrutiny by EEA EFTA
Draft Joint Committee Decision (JCD) under consideration
Entry into force of Joint Committee Decision (JCD) pending
Incorporated into the EEA Agreement and in force
Incorporated into the EEA Agreement but no longer in force
Legal status
EU legal act incorporated into the EEA Agreement by a Joint Committee Decision (JCD)
Area (EEA Agreement)
I Veterinary and Phytosanitary Matters
I.II Feedingstuffs
Joint committee decision (JCD)
007/2026
In force in the EEA
Yes
Legal Documents
Commission Implementing Regulation (EU) 2025/1795 of 9 September 2025 concerning the authorisation of riboflavin (vitamin B2) produced with Bacillus subtilis CGMCC 7.449 and a preparation of riboflavin produced with Bacillus subtilis CGMCC 7.449, as feed additives for all animal species
Framkvæmdarreglugerð framkvæmdastjórnarinnar (ESB) 2025/1795 frá 9. september 2025 um leyfi fyrir ríbóflavíni (B2-vítamíni), sem er framleitt með Bacillus subtilis CGMCC 7.449, og blöndu með ríbóflavíni, sem er framleitt með Bacillus subtilis CGMCC 7.449, sem fóðuraukefni fyrir allar dýrategundir
Durchführungsverordnung (EU) 2025/1795 der Kommission vom 9. September 2025 zur Zulassung von Riboflavin (Vitamin B2), hergestellt mit Bacillus subtilis CGMCC 7.449, und einer Zubereitung aus Riboflavin, hergestellt mit Bacillus subtilis CGMCC 7.449, als Zusatzstoffe in Futtermitteln für alle Tierarten
History
Disclaimer: EEA-Lex is provided for information purposes only. The information is not guaranteed or promised to be current or complete and is not intended to replace any applicable legal sources.